Denisa Streitova
Overview
Explore the profile of Denisa Streitova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hofer M, Pospisil M, Sefc L, Dusek L, Vacek A, Hola J, et al.
Int J Radiat Biol
. 2010 Jul;
86(8):649-56.
PMID: 20586541
Purpose: Research areas of 'post-exposure treatment' and 'cytokines and growth factors' have top priority among studies aimed at radiological nuclear threat countermeasures. The experiments were aimed at testing the ability...
2.
Krejci J, Harnicarova A, Streitova D, Hajek R, Pour L, Kozubek S, et al.
Leuk Res
. 2009 Apr;
33(11):1490-8.
PMID: 19362368
Genetic and epigenetic changes in multiple myeloma (MM) correlate with the stage of the disease. Therefore, we investigated how cytostatics and gamma radiation influence MM-associated histone modifications. ChIP-PCR and ChIP-on-chip...
3.
Hofer M, Pospisil M, Znojil V, Hola J, Streitova D, Vacek A
Exp Biol Med (Maywood)
. 2008 May;
233(7):897-900.
PMID: 18445770
Two adenosine receptor agonists, N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and N6-cyclopentyladenosine (CPA), which selectively activate adenosine A3 and A1 receptors, respectively, were tested for their ability to influence proliferation of granulocytic and erythroid...
4.
Streitova D, Weiterova L, Hofer M, Hola J, Horvath V, Kozubik A, et al.
Cancer Invest
. 2007 Sep;
25(6):419-26.
PMID: 17882653
Adenosine has been observed to suppress the growth of MOLT-4 human leukemia cells in vitro. Changes in the cell cycle, especially increased percentage of cells in S phase, prolonged generation...
5.
Hofer M, Vacek A, Lojek A, Hola J, Streitova D
Int Immunopharmacol
. 2007 Aug;
7(10):1369-74.
PMID: 17673152
A low-molecular-weight (<12 kDa) ultrafiltered pig leukocyte extract, IMUNOR, was tested in experiments in vitro on non-stimulated and lipopolysaccharide (LPS)-stimulated murine RAW 264.7 macrophages in order to assess modulation of...
6.
Vacek A, Hofer M, Hola J, Weiterova L, Streitova D, Svoboda J
Int Immunopharmacol
. 2007 Mar;
7(5):656-61.
PMID: 17386413
IMUNOR, a low-molecular weight (< 12 kD) ultrafiltered pig leukocyte extract, has been previously found to have significant stimulatory effects on murine hematopoiesis supressed by ionizing radiation or cytotoxic drugs....
7.
Hofer M, Pospisil M, Znojil V, Hola J, Vacek A, Streitova D
Biomed Pharmacother
. 2007 Mar;
61(6):356-9.
PMID: 17383145
The present study was performed to define the optimum conditions of the stimulatory action of the adenosine A(3) receptor agonist, N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA), on bone marrow hematopoiesis in mice. Effects of...
8.
Hofer M, Pospisil M, Vacek A, Hola J, Znojil V, Weiterova L, et al.
Eur J Pharmacol
. 2006 Apr;
538(1-3):163-7.
PMID: 16643889
The purpose of the experiments reported was to investigate effects of N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA), a selective adenosine A(3) receptor agonist, on the granulocytic system in femoral marrow of mice depleted by...